Skip to main content

Klompas Neil A's Form 4 filing

Zymeworks Inc. (ZYME) · filed Mar 14, 2023

Accession no.
0000899243-23-008432
Filed
Mar 14, 2023
Trade date
Mar 10, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $23.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klompas Neil ACIK 0001761857Officer (President & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseAcquired+2,500$0.00$017,301Direct
Mar 10, 2023Common StockMOption exerciseAcquired+2,708$0.00$020,009Direct
Mar 10, 2023Common StockSSaleDisposed−2,977$7.83−$23,309.9117,032Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseDisposed−2,500$0.00$00Direct
Mar 10, 2023Common StockMOption exerciseDisposed−2,708$0.00$02,709Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)